Interferon treatment for chronic Hepatitis C: A family impact study

Gastroenterology Nursing

Volumn 32, Issue 6, 2009, Pages 377-383

  Blacklaws, Helen ^a   Veysey, Heather ^a   Skinner, Virginia ^a   Reid, Rachel Sheather ^a   Hawken, Glenn ^b   Veysey, Martin ^a  

^a New South Wales Government   (Australia)

^b Central Coast Health Service   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; INTERFERON;

ADAPTIVE BEHAVIOR; ANGER; ARTICLE; CONFIDENTIALITY; COPING BEHAVIOR; FAMILY; FAMILY RELATION; HEALTH SURVEY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFORMATION PROCESSING; ISOLATION AND PURIFICATION; NURSING; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE;

ADAPTATION, PSYCHOLOGICAL; ANGER; ANTIVIRAL AGENTS; CONFIDENTIALITY; FAMILY; FAMILY RELATIONS; FOCUS GROUPS; HEALTH SURVEYS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; QUALITY OF LIFE; QUESTIONNAIRES; RESILIENCE, PSYCHOLOGICAL;

EID: 74049102037     PISSN: 1042895X     EISSN: 15389766     Source Type: Journal    
DOI: 10.1097/SGA.0b013e3181c10759     Document Type: Article

References (14)

1. Alberti, A., Chemello, L., & Benvegnu, L. (1999). Natural history of hepatitis C. Hepatology, 31(Suppl. 1), 17-24.
2. Alter, H. J. (1999). Discovery of non-A, non-B hepatitis and identification of its etiology. American Journal of Medicine, 107(6B), 16S-20S.
3. Balkrishnan, R., Houseman, T. S., Carroll, C., Feldman, S. R., & Fleischer, A. B. (2003). Disease severity and associated family impact in childhood atopic dermatitis. Archives of Disease in Childhood, 88, 423-427. (Pubitemid 36566728)
4. D'Souza, R., & Foster, G. R. (2004). Diagnosis and treatment of hepatitis C. Journal of the Royal Society of Medicine, 97(5), 223-225.
5. Freeman, A. J., Dore, G. J., & Law, M. G. (2001) Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology, 34(4), 809-816.
6. Gerlach, J. T., Diepolder, H. M., & Zachoval, R. (2003). Acute hepatitis C: High rate of both spontaneous and treatment-induced viral clearance. Gastroenterology, 125(80), 80-88.
7. Gohier, B., Goeb, J. L., Rannou-Dubas, K., Fouchard, I., Cales, P., & Garre, J. B. (2003). Hepatitis C, alpha interferon, anxiety and depression disorders: A prospective study of 71 patients. World Journal of Biological Psychiatry, 4(3), 115-118.
8. Grunfield, E., Coyle, D., Whelan, T., Clinch, J., Reyno, L., Earle, C., et al. (2004). Family caregiver burden: Results of a longitudinal study of breast cancer patients and their principal caregivers. Canadian Medical Association Journal, 170(12), 1795-1801.
9. Hadziyannis, S. J., Sette, H., Jr., & Morgan, T. R. (2004). Peginterferon-alpha 2a and ribavirin combination therapy in chronic hepatitis C. Annals of Internal Medicine, 140(5), 346-355.
10. Hopwood, M., & Treloar, C. (2005). The experience of interferonbased treatments for hepatitis C infection. Qualitative Health Research, 15(5), 635-646.
11. Schrag, A., Morley, D., Quinn, N., & Jahanshahi, M. (2004). Impact of Parkinson's disease on patient's adolescent and adult children. Parkinsonism & Related Disorders, 10(7), 391-397.
12. Tremont, G., Duncan-Davis, J., & Bishop, D. S. (2006). Unique contribution of family functioning in caregivers of patients with mild to moderate dementia. Dementia and Geriatric Cognitive Disorders, 21(3), 170-174.
13. World Health Organization. (1999). Global surveillance and control of hepatitis C. Journal of Viral Hepatitis, 6, 35-47.
14. Yoshida, H., Tateishi, R., Arakawa, Y., Sata, M., Fujiyama, S., Nishiguchi, S., et al. (2004). Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C. Gut, 53(3), 425-430.